Ascend Laboratories, LLC has recalled several lots of Rizatriptan Benzoate Tablets (5 mg and 10 mg), a prescription medication used to treat migraine headaches. The recall was issued because testing detected an impurity called N-nitroso-dimethyl-rizatriptan at levels higher than the FDA’s recommended daily intake limit. If you have any health concerns about using this product, please contact your healthcare provider or pharmacist.
The tablets contain an impurity known as a nitrosamine, which may increase the risk of cancer if people are exposed to levels above acceptable limits over a long period of time. No specific injuries or adverse health effects have been reported to date in connection with this recall.
You have 2 options:
Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories LLC.
Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.